LVAD Developers Look To Medicare Coverage Decision To Offset Trial Costs

Launch of clinical trials for the DeBakey LVAD as destination therapy for end-stage heart failure patients is contingent on CMS issuing a national coverage decision for the expanded claim, MicroMed maintains